Molecure S.A.: Clinical Trials

2 trials sponsored by Molecure S.A., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow Molecure S.A.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis
OATD-01, Placebo - Pulmonary Sarcoidosis
Phase 2RecruitingMolecure S.A.962024-03-212026-10-08
First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients With Selected Advanced and/or Metastatic Solid Tumours
OATD-02 - Advanced Ovarian Carcinoma, Advanced Renal Cell Carcinoma
Phase 1RecruitingMolecure S.A.402023-01-262026-07-31

Conditions studied

Carcinoma, Renal Cell (1)  ·  Colorectal Neoplasms (1)  ·  Kidney Neoplasms (1)  ·  Ovarian Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Sarcoidosis (1)  ·  Sarcoidosis, Pulmonary (1)

Interventions

OATD-01 (1)

Countries

Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Poland (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Dariusz Stencel, MD (1)

NIH funding

2023 (1)